Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0VP9E
|
|||
| Former ID |
DIB006966
|
|||
| Drug Name |
Cyrtominetin
|
|||
| Synonyms |
IdB-1031; D,L-5,7,3',4'-Tetrahydroxy-6,8-dimethylflavanone; Rac-5,7-Dihydroxy-2-(3,4-dihydroxyphenyl)-6,8-dimethyl-2,3-dihydro-4H-1-benzopyran-4-one
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Phlegmy cough [ICD-11: SA80-SA8Z; ICD-10: J00-J99] | Phase 3 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H16O6
|
|||
| Canonical SMILES |
CC1=C(C(=C2C(=C1O)C(=O)CC(O2)C3=CC(=C(C=C3)O)O)C)O
|
|||
| InChI |
1S/C17H16O6/c1-7-15(21)8(2)17-14(16(7)22)12(20)6-13(23-17)9-3-4-10(18)11(19)5-9/h3-5,13,18-19,21-22H,6H2,1-2H3
|
|||
| InChIKey |
AESMRHCYHARBLU-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 95272-99-4
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Staphylococcus Alpha-hemolysin (Stap-coc hly) | Target Info | Modulator | [1] |
| Reactome | The NLRP3 inflammasome | |||
| WikiPathways | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Molecular insight into the inhibition mechanism of cyrtominetin to alpha-hemolysin by molecular dynamics simulation. Eur J Med Chem. 2013 Apr;62:320-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.